Synthesis and biological activities of benzothiazole derivatives: A review

Abstract

The research and development of benzothiazole derivatives have gained significant interest in recent years due to their diverse range of pharmacological activities. Benzothiazole-based compounds have been found to be effective in the treatment of various diseases including cancer, microbial infections and cardiovascular diseases. The synthesis of benzothiazole derivatives has been an active area of research, and several synthetic methods have been developed to access these compounds. The development of new.synthetic approaches and the modification of existing methods have allowed for the creation of novel scaffolds with improved biological properties and specificity. Benzothiazole derivatives have exhibited a wide range of biological activities including antitumor, antibiotic, antifungal, antimicrobial, HIV–I protease inhibition, and antiarteriosclerosis activities. The exploration of the pharmacological properties of benzothiazole derivatives continues to be an exciting area of research with the potential for the discovery of new drugs and therapies. Present review of benzothiazole and its derivatives provides a comprehensive overview of their synthesis and biological activities. This review will serve as a useful resource for researchers working in the field of synthetic chemistry and drug discovery, and it is expected to inspire further research and development of benzothiazole-based compounds with enhanced pharmacological properties.

Keywords

Benzothiazole / Synthesis / Pharmacological activities / Heterocyclics

References

[1] Ingle RG, Marathe RP. Review on literature study of benzothiazole. Int J Pharmaceut Res Allied Sci. 2012; 1 (4): 11- 15.

[2] Khare E, Sharma S, Singh Y, Keshri P. A comprehensive review on the biological aspects of emerging benzothiazole. Pharma. 2019; 7 (2): 1- 8.

[3] Pathak N, Rathi E, Kumar N, Kini SG, Rao CM. A review on anticancer potentials of benzothiazole derivatives. Mini-Rev Med Chem. 2020; 20 (1): 12- 23.

[4] Asif M, Imran M. A mini-review on pharmacological importance of benzothiazole scaffold. Rev Organic Chem. 2021; 18 (8): 1086- 1097.

[5] Gao X, Liu J, Zuo X, Feng X, Gao Y. Recent advances in synthesis of benzothiazole compounds related to green chemistry. Molecules. 2020; 25 (7): 1675.

[6] Yadav PS, Prakash D, Senthilkumar GP. Different methods of synthesis of benzothiazole and diverse biological activities. Int J Pharmaceut Sci Drug Res. 2011; 3 (1): 1- 7.

[7] Aljamali DNM, Chfat HG, Jawd DSM. Benzothiazol derivatives (synthesis, investigation, bio-studying). Int J Pharmaceut Res. 2019; 11 (1): 1- 8.

[8] Lihumis HS, Alameri AA, Zaooli RH. Recent development and biological applications of benzothiazole derivatives. Progr Chem Biochem Res. 2022; 5 (2): 147- 164.

[9] Sharma S, Pathare RS, Maurya AK, et al. Ruthenium catalyzed intramolecular C-S coupling reactions: synthetic scope and mechanistic insight. Org Lett. 2016; 18 (3): 356- 359.

[10] Heo Y, Song Y, Kim B, Heo J. A highly regioselective synthesis of 2-aryl-6-chloro-benzothiazoles employing microwave-promoted Suzuki-Miyaura coupling reaction. Tetrahedron Lett. 2006; 47: 3091- 3094.

[11] Gulati S, Wakode S, Kaur A, Anand K. Synthesis, biological activity and recent advancement of benzothiazoles : a classical review. World J Pharm Pharmaceut Sci. 2017; 6 (6): 1842- 1869.

[12] Keri RS, Patil MR, Patil SA, Budagumpi S. A comprehensive review in current developments of Benzothiazole based molecules in medicinal chemistry. Eur J Med Chem. 2015; 89: 207- 251.

[13] Zhilitskaya LV, Shainyan BA, Yarosh NO. Modern approaches to the synthesis and transformations of practically valuable benzothiazole derivatives. Molecules. 2021; 26 (8): 2190.

[14] Kumar S, Mittal A, Pathak A, Sahu Sk. Biological assessments of substituted benzothiazole derivatives in streptozocin induced diabetes rats. Plant Archives. 2020; 20 (2): 3250- 3253.

[15] Shaista A, Amrita P. Benzothiazole - a magic molecule. Int J Pharmaceut Sci Res. 2017; 8 (12): 4909- 4929.

[16] Tariq S, Alam O, Amir M. Synthesis p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines. Arch. Pharm. Chem. Life Sci. 2018;351(3–4), 1700304.

[17] Tariq S, Kamboj P, Alam O, Amir M. 1,2, 4-Triazole-based benzothiazole/benzoxazole derivatives: design, synthesis, p38α MAP kinase inhibition, antiinflammatory activity and molecular docking studies. Bioorg Chem. 2018; 81 (9): 630- 641.

[18] El-Sharief S, Ammar Y, Zahran M, Sabet HK. Phosphorus, Sulfur Silicon Related Element. vol. 179. 2004:267–275.

[19] Nguyen TB, Ermolenko L, Dean WA, Al-Mourabit A. Benzazoles from aliphatic amines and o-amino/mercaptan/hydroxyanilines - elemental sulfur as a highly efficient and traceless oxidizing agent. Org Lett. 2012; 14: 5948- 5951.

[20] Evindar G, Batey RA. Copper- and palladium-catalyzed intramolecular aryl guanidinylation: an efficient method for the synthesis of 2-aminobenzimidazoles. Org Lett. 2003; 5 (2): 133.

[21] Gupta A, Rawat S. Synthesis and cyclization of benzothiazole: review. J Curr Pharmaceut Res. 2010; 3 (1): 13- 23.

[22] Ugwu DL, Okoro UC, Ukoha PO, Gupta A, Okafor SN. Novel anti-inflammatory and analgesic agent: synthesis, molecular docking and in-vivo studies. J Enzym Inhib Med Chem. 2018; 33 (1): 405- 415.

[23] Osmaniy D, Levent S, Karaduman AB, Ilgın S, Özkay Y, Kaplancıklı ZA. Synthesis of new benzothiazole acylhydrazones as anticancer agents. Molecules. 2018; 23 (5): 1054.

[24] Gupta K, Sirbaiya AK, Kumar V, Rahman MA. Current perspective of synthesis of medicinally relevant benzothiazole based molecules: potential for antimicrobial and anti-inflammatory activities. Mini Rev Med Chem. 2022; 22 (14): 1895- 1935.

[25] Hutchinson I, Chua MS, Browne HL, et al. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl) benzothiazoles. J Med Chem. 2001;44(9):1446–1455.

[26] Bhuva HA, Kini SG. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors. J Mol Graph Model. 2010; 29 (1): 32- 37.

[27] Hutchinson I, Sahin B, Yaglioglu AS, Ceylan M. Synthesis and cytotoxic activities of novel 2-(1,5-bis (aryl) penta-1,4-dien-2-yl) benzo[d]thiazol derivatives. Org Commun. 2016; 9 (3): 65.

[28] Manjula SN, Noolvi NM, Parihar KV, et al. Synthesis and antitumor activity of optically active thiourea and their 2-aminobenzothiazole derivatives: a novel class of anticancer agents. Eur J Med Chem. 2009; 44 (7): 2923- 2929.

[29] Saeed S, Rashid N, Jones PG, Ali M, Hussain R. Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents. Eur J Med Chem. 2010; 45 (4): 1323- 1331.

[30] Lesyk BR, Zimenkovsky BS. 4-Thiazolidones: centenarian history, current status and perspectives for modern organic and medicinal chemistry. Curr Org Chem. 2004; 8 (16): 1547- 1577.

[31] Havrylyuk D, Mosula L, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur J Med Chem. 2010; 45 (11): 5012- 5021.

[32] Wang K, Guengerich FP. Bioactivation of fluorinated 2-arylbenzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1. Chem Res Toxicol. 2012; 25 (8): 1740- 1751.

[33] Bolelli K, Musdal Y, Aki-Yalcin E, Mannervik B, Yalcin I. Synthesis and activity mechanism of some novel 2-substituted benzothiazoles as hGSTP1-1 enzyme inhibitors. SAR QSAR Environ Res. 2017; 28 (11): 927- 940.

[34] Morsy MA, Ali EM, Kandeel M, et al. Screening and molecular docking of novel benzothiazole derivatives as potential antimicrobial agents. Antibiotics. 2020; 9 (5): 221.

[35] Lee M, Chan CW, Graham SC, Christopherson RI, Guss JM, Maher MJ. Structures of ligand-free and inhibitor complexes of dihydroorotase from Escherichia coli: implications for loop movement in inhibitor design. J Mol Biol. 2007; 370: 812- 825.

[36] Maddili SK, Li Z, Kannekanti VK, et al. Azoalkyl ether imidazo[2,1-b]benzothiazoles as potentially antimicrobial agents with novel structural skeleton. Bioorganic Med. Chem Lett. 2018;28(1):2426–2431.

[37] Thakkar SS, Thakor P, Ray A, Doshi H, Thakkar VR. Benzothiazole analogues: synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities. Bioorg Med Chem. 2017; 25 (20): 5396- 5406.

[38] Rice AJ, Lei H, Santarsiero BD, Lee H, Johnson ME. Ca-asp bound X-ray structure and inhibition of Bacillus anthracis dihydroorotase (DHOase). Bioorg Med Chem. 2016; 24: 4536- 4543.

[39] Truong L, Hevener KE, Rice AJ, Patel K, Johnson ME, Lee H. High-level expression, purification, and characterization of Staphylococcus aureus dihydroorotase (PyrC) as a cleavable His-SUMO fusion. Protein Expr Purif. 2013; 88 (1): 98- 106.

[40] Khokra SL, Arora K, Mehta H, Aggarwal A, Yadav M. Common methods to synthesize benzothiazole derivatives and their medicinal significance: a review. Int J Pharmaceut Sci Res. 2011; 2 (6): 1356- 1377.

[41] Nagaraj Chaluvaraju KC, Niranjan MS, Kiran S. 3,4-Oxadiazole: a potent drug candidate with various pharmacological activities. Int J Pharm Pharmaceut Sci. 2011; 3 (3): 9- 16.

[42] Geller R, Taguwa S, Frydman J. Broad action of Hsp90 as a host chaperone required for viral replication. Biochim Biophys Acta. 2012; 1823 (3): 698, 670.

[43] Azzam RA, Osman RR, Elgemeie GH. Efficient synthesis and docking studies of novel benzothiazole-based pyrimidinesulfonamide scaffolds as new antiviral agents and HSP90A inhibitors. ACS Omega. 2020; 5 (3): 1640- 1655.

[44] Kumar A, Shakya AK, Siddiqui HH. Synthesis and anti-inflammatory activity of some novel 2-aminobenzothiazole derivatives. Indian J Heterocycl Chem. 2016; 25: 243- 249.

[45] Kumar N, Chowdhary A, Gudaparthi O, Patel NG, Soni SK, Sharma P. A simple and highly efficient process for synthesis of Gefitinib and its intermediate. Indian J Chem. 2014;53B:1269–1274.

[46] Venkatesh P, Pandeya SN. Synthesis, characterization and anti-inflammatory activity of some 2-amino benzothiazole derivatives. Int J ChemTech Res. 2009; 1 (4): 1354- 1358.

[47] Sathe BS, Jaychandran E, Jagtap VA, Sreenivasa GM. Anti-tubercular activity of fluoro benzothiazole comprising potent thaizolidinone. Int J Pharma Bio Sci. 2010; 1 (4): 495- 500.

[48] Wang Z, Shi XH, Wang J, et al. Synthesis, structure activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers. Bioorg Med Chem Lett. 2011; 21 (4): 1097- 1101.

[49] Guillemont JEG, Motte MMS, Koul A, Lounis N. Antimycobactrial Compounds. WO096300. 2014.

[50] Pellet A. Nitrobenzothiazole Derivatives, Their Preparation, and Their Use in Treating Tuberculosis. 2012:2–3. WO069743.

[51] Djuidje EN, Barbari R, Baldisserotto A, et al. Benzothiazole derivatives as multifunctional antioxidant agents for skin damage: structure-activity relationship of a scaffold bearing a five-membered ring system. Antioxidants. 2022; 11 (2): 407.

[52] Meltzer-Mats E, Babai-Shani G, Pasternak L, et al. Synthesis and mechanism of hypoglycemic activity of benzothiazole derivatives. J Med Chem. 2013; 56 (13): 5335- 5350.

[53] Bhagdev K, Sarkar S. Benzothiazole: as an antidiabetic agent. Annals of R.S.C.B. 2021; 25(4):20269–20285.

[54] Usman B, Mahajan S, Mehta M, et al. Prediction of alpha-glucosidase inhibition activity for the management of type 2 diabetes using the prediction of activity spectra of substances software. Asian J Pharm. 2019; 13 (3): 225- 232.

[55] Hussain S, Taha M, Rahim F, et al. Synthesis of benzimidazole derivatives as potent inhibitors for α-amylase and their molecular docking study in management of type-II diabetes. J Mol Struct. 2021;1232, 130029.

[56] Mor S, Sindhu S. Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno[1,2-c]pyrazol-4(1H)-ones. Med Chem Res. 2020; 29 (1): 46- 62.

[57] Gong Z, Peng Y, Qiu J, Cao A, Wang G, Peng Z. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of novel benzothiazole-triazole derivatives. Molecules. 2017; 22 (9): 1555.

[58] Keri RS, Quintanova C, Marques SM, Esteves AR, Cardoso SM, Santos MA. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease. Bioorg Med Chem. 2013; 21 (15): 4559- 4569.

[59] DeKosky ST, Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science. 2003; 302 (5646): 830- 834.

[60] Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology. 1998; 50: 136- 145.

[61] Cummings JL. Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatr. 2000; 157 (1): 4- 15.

[62] Majo VJ, Prabhakaran J, Mann JJ, Kumar JSD. An efficient palladium catalyzed synthesis of 2-arylbenzothiazoles. Tetrahedron Lett. 2003; 44: 8535- 8537.

[63] Kochanowska-Karamyan AJ, Hamann MT. Marine indole alkaloids: potential new drug leads for the control of depression and anxiety. Chem Rev. 2010; 110 (8): 4489- 4497.

[64] Fu Y, Gong J-X, Wang Z-Z, Xiao W, Zhang H-Y, Guo Y-W. Isorhapontigenin prevents β-amyloid-associated cognitive impairments through activation of the PI3K/AKT/GSK-3β pathway. Bioorg Med Chem Lett. 2015; 25: 216.

[65] Hassan MZ, Khan SA, Amir M. Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl) amides as anticonvulsant and neuroprotective. Eur J Med Chem. 2012; 58: 206- 213.

[66] Unverferth K, Engel J, Höfgen N, et al. Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles. J Med Chem. 1998; 41 (1): 63- 73.

[67] Waterbeemed V. Quantitative approaches to structure activity relationships. In: Wermuth CG, ed. The Practice of Medicinal Chemistry. vol. 4. London: Academic Press; 1996:367.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).